Malignant bowel obstruction in advanced ovarian cancer

被引:13
作者
Dean, Emma [1 ,2 ,3 ]
Khoja, Leila [1 ,2 ,4 ]
Clamp, Andrew [1 ,2 ,3 ]
Jayson, Gordon C. [1 ,2 ,3 ]
Goonetilleke, Dilly [1 ,2 ,3 ]
Conway, Alicia M. [1 ,2 ]
Hasan, Jurjees [1 ,2 ]
机构
[1] Christie NHS Fdn Trust, Manchester M20 4BX, Lancs, England
[2] Inst Canc Sci, Manchester M20 4BX, Lancs, England
[3] Univ Manchester, Div Mol & Clin Canc Sci, Manchester M13 9NT, Lancs, England
[4] AstraZeneca Ltd, Early Clin Dev, Melbourn Sci Pk, Melbourn SG8 6HB, Herts, England
关键词
bowel obstruction; Manchester Bowel Obstruction Score; ovarian cancer; prognostic score; MANAGEMENT; OUTCOMES;
D O I
10.2217/fon-2016-0431
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Malignant bowel obstruction (MBO) in ovarian cancer is poorly understood. Methods: This retrospective cohort study analyzed 129 patients with ovarian cancer and MBO. Results: At presentation, 69 (53%) had platinum-resistant, 37 (29%) platinum-sensitive and 23 (18%) chemotherapy-naive disease. In patients receiving chemotherapy following the MBO episode, median overall survival (OS) was 107 days for chemotherapy-naive patients compared with 83 and 86 for platinum-sensitive or platinum-resistant patients (p = 0.98). OS was inferior for best supportive care (45 days) compared with chemotherapy (152 days) or surgery (124 days; p < 0.001). The Manchester Bowel Obstruction Score using Eastern Cooperative Oncology Group and obstruction level discriminated patients by median OS of 181 days (neither) versus 98 days (one) versus 42 days (both; p < 0.01). Conclusion: The Manchester Bowel Obstruction Score may aide treatment stratification.
引用
收藏
页码:513 / 521
页数:9
相关论文
共 50 条
[41]   Malignant Large Bowel Obstruction [J].
Muldoon, Roberta L. .
CLINICS IN COLON AND RECTAL SURGERY, 2021, 34 (04) :251-261
[42]   Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer [J].
Xingang Peng ;
Peige Wang ;
Shikuan Li ;
Guangyong Zhang ;
Sanyuan Hu .
World Journal of Surgical Oncology, 13
[43]   Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer [J].
Peng, Xingang ;
Wang, Peige ;
Li, Shikuan ;
Zhang, Guangyong ;
Hu, Sanyuan .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
[44]   Outcomes of palliative surgery for bowel obstruction in end of life ovarian cancer care in a tertiary cancer centre [J].
Kennedy, Bernard ;
Sexton, Kate ;
Gleeson, Noreen .
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (06) :1112-1115
[45]   Malignant Bowel Obstruction: A Review of Current Treatment Strategies [J].
Dolan, Elisabeth A. .
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2011, 28 (08) :576-582
[46]   Malignant bowel obstruction: effectiveness and safety of systemic chemotherapy [J].
Caparica, Rafael ;
Amorim, Larissa ;
Amaral, Paulo ;
Uratani, Lucas ;
Muniz, David ;
Hendlisz, Alain ;
de Azambuja, Evandro ;
Glasberg, Joao ;
Takahashi, Tiago Kenji ;
Filho, Elias Abdo ;
Canellas, Rodrigo ;
Saragiotto, Daniel ;
Sabbaga, Jorge ;
Mak, Milena .
BMJ SUPPORTIVE & PALLIATIVE CARE, 2024, 14 (E2) :e1882-e1888
[47]   MANAGEMENT OF BOWEL OBSTRUCTION IN ADVANCED AND TERMINAL CANCER-PATIENTS [J].
RIPAMONTI, C ;
DECONNO, F ;
VENTAFRIDDA, V ;
ROSSI, B ;
BAINES, MJ .
ANNALS OF ONCOLOGY, 1993, 4 (01) :15-21
[48]   A scoring system for the prognosis and treatment of malignant bowel obstruction [J].
Henry, Jon C. ;
Pouly, Severin ;
Sullivan, Rachael ;
Sharif, Suhail ;
Klemanski, Dori ;
Abdel-Misih, Sherif ;
Arradaza, Nicole ;
Jaijoura, David ;
Schmidt, Carl ;
Bloomston, Mark .
SURGERY, 2012, 152 (04) :747-757
[49]   Octreotide for malignant bowel obstruction: Twenty years after [J].
Mercadante, Sebastiano ;
Porzio, Giampiero .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 83 (03) :388-392
[50]   Palliative surgery of malignant small bowel obstruction after colorectal cancer [J].
Koisser, Karin .
WIENER MEDIZINISCHE WOCHENSCHRIFT, 2019, 169 (15-16) :381-386